PEAR THERAPEUTICS Stock Price, News & Analysis
THMAU
NASDAQ
Company Description
PEAR THERAPEUTICS (NASDAQ: THMAU) is a publicly traded company.
THMAU stock has declined 4.3% over the past year.
This page provides a comprehensive overview of THMAU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-4.35%
Performance 1 year
$0.0
20.0M
PEAR THERAPEUTICS (THMAU) stock. Over the past 12 months, the stock has lost 4.3%.
Latest News
PEAR THERAPEUTICS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, fda approval, acquisition, IPO, offering. View all THMAU news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months